IFNA1 and systemic lupus erythematosus: Furthermore, transcriptomic changes in BPA-treated lymphoblastoid cells demonstrated sensitivity to BPA in both type I and II IFN responses, further supporting that BPA elicits transcriptional programmes relevant to the pathogenesis of SLE.